In contrast, high expression of IDO1 was detected in majority (93.33%, 14/15) of stage III lung adenocarcinomas, with only 6.7% (1/15) of stage III tumor tissues showed low expression of IDO1 (P < 0.01). Here, IDO1 is linked to lung adenocarcinoma.